MANHASSET, N.Y.–(BUSINESS WIRE)–There might be a new, non-pharmacological way to treat major mental health disorders like schizophrenia spectrum disorders and psychosis. Researchers at The Feinstein Institutes for Medical Research have received a $3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects. Already approved by the U.S. Food and Drug … [Read more…]

FREDERICK, Md.–(BUSINESS WIRE)–#Awards–The Maryland Tech Council, the largest technology and life science trade association in the state, announced the winners of its 2023 ICON Awards Thursday at the Bethesda North Marriott Hotel & Conference Center. “We are excited to recognize these outstanding leaders and companies,” said Kelly Schulz, CEO of the Maryland Tech Council. “In … [Read more…]

Company Reports Financial Results for the Nine Months Ended December 31, 2022 Business Combination Remains on Track to Close in the Second Quarter of 2023 DALLAS–(BUSINESS WIRE)–NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), and Yotta Acquisition Corporation (Nasdaq: YOTA) (“Yotta”), … [Read more…]

LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced that Shaun Bagai, CEO of RenovoRx, will present at the Aegis Capital Virtual Conference on May 3rd at 3:30 p.m. ET. The online presentation can be accessed here. The conference will be … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023. 2seventy bio will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Participants can access the conference call live … [Read more…]

 – CEO Doug Drysdale to speak on a mental health panel on May 2, 2023 – TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking … [Read more…]

Recommendations for high-risk expecting parents and health care providers to promote the prevention of preeclampsia, a leading cause of pregnancy-related death in the United States SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–A new special report published in the American Journal of Obstetrics and Gynecology (AJOG) provides a groundbreaking approach to preeclampsia, one of the most pressing issues … [Read more…]

BOSTON–(BUSINESS WIRE)–Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that it will present information on STAR-0215 and its development in two presentations at the 13th C1-Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary. … [Read more…]

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced an underwritten public offering of 3,750,000 shares of its common stock and warrants to purchase 1,875,000 shares of its common stock. The warrants are being sold at … [Read more…]

CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the use of the Renuvion APR Handpiece “for coagulation of subcutaneous soft tissues following liposuction for … [Read more…]